ArticleClinical and molecular hepatology2020

Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment.

Cheol-Hyung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.